Mirum Pharmaceuticals (MIRM) Prepaid Assets (2018 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Prepaid Assets of $24.5 million for Q1 2026, up 65.03% year-over-year from $14.9 million in Q1 2025, and up 35.31% quarter-over-quarter from $18.1 million in Q4 2025.
Analysis
Mirum Pharmaceuticals (MIRM) Prepaid Assets (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Prepaid Assets history runs 9 years deep, the most recent figure standing at $24.5 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 65.03% year-over-year to $24.5 million; the TTM figure through Mar 2026 stood at $24.5 million (up 65.03% YoY), while the FY2025 annual figure was $18.1 million, up 53.94% from the prior year.
- Prepaid Assets for Q1 2026 stood at $24.5 million, up from $18.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $24.5 million in Q1 2026, with the low at $3.8 million in Q2 2022.
- The 5-year median for Prepaid Assets is $10.9 million (2023), against an average of $12.4 million.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets slipped 16.32% in 2022, then surged 157.52% in 2023.
- Mirum Pharmaceuticals' Prepaid Assets stood at $8.9 million in 2022, then increased by 22.22% to $10.9 million in 2023, then advanced by 7.76% to $11.8 million in 2024, then surged by 53.94% to $18.1 million in 2025, then soared by 35.31% to $24.5 million in 2026.
- Business Quant data shows MIRM's Prepaid Assets at $24.5 million in Q1 2026, $18.1 million in Q4 2025, and $23.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.89 Mn |
| Mar 31, 2026 | 24.55 Mn |
| Dec 31, 2025 | 18.14 Mn |
| Sep 30, 2025 | 23.87 Mn |
| Jun 30, 2025 | 19.07 Mn |
| Mar 31, 2025 | 14.87 Mn |
| Dec 31, 2024 | 11.78 Mn |
| Sep 30, 2024 | 12.06 Mn |
| Jun 30, 2024 | 8.59 Mn |
| Mar 31, 2024 | 10.02 Mn |
| Dec 31, 2023 | 10.94 Mn |
| Sep 30, 2023 | 12.47 Mn |
| Jun 30, 2023 | 9.73 Mn |
| Mar 31, 2023 | 8.99 Mn |
| Dec 31, 2022 | 8.95 Mn |
| Sep 30, 2022 | 6.93 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.91 Mn |
| Dec 31, 2021 | 5.27 Mn |
| Sep 30, 2021 | 6.37 Mn |